Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Dec 17.

Published in final edited form as: Cochrane Database Syst Rev. 2013 Dec 3;12:CD005431. doi: 10.1002/14651858.CD005431.pub3

Table 7.

Risk of other ocular events

Study	Outcome	Test intervention	No. with outcome/No. in group	Control intervention	No. with outcome	Total No./No. with outcome
*Aminocaproic acid*
Crouch 1997	Conjunctival/corneal foreign body sensation	Topical aminocaproic acid	4/35	Oral aminocaproic acid	0/29	4/64
Crouch 1997	Transient punctate corneal staining	Topical aminocaproic acid	3/35	Oral aminocaproic acid	0/29	3/64
*Tranexamic acid*
Varnek 1980	Vitreous and retinal hemorrhage	Tranexamic acid	5/102	Conservative treatment	5/130	10/232
Varnek 1980	Traumatic cataract	Tranexamic acid	2/102	Conservative treatment	0/130	2/232
*Nondrug medical intervention*
Read 1974	Traumatic cataract	Moderate ambulatory activity, patching and shielding of injured eye	NR	Bed rest with elevation of the head, bilateral patches and eye shield	NR	8/137
	Vitreous hemorrhage	Moderate ambulatory activity, patching and shielding of injured eye	NR	Bed rest with elevation of the head, bilateral patches and eye shield	NR	11/137
	Commotio retinae	Moderate ambulatory activity, patching and shielding of injured eye	NR	Bed rest with elevation of the head, bilateral patches and eye shield	NR	4/137
	Occluded pupil	Moderate ambulatory activity, patching and shielding of injured eye	NR	Bed rest with elevation of the head, bilateral patches and eye shield	NR	2/137
	Optic atrophy with nasalization of optic cup	Moderate ambulatory activity, patching and shielding of injured eye	NR	Bed rest with elevation of the head, bilateral patches and eye shield	NR	4/137
	Optic atrophy without nasalization of optic cup	Moderate ambulatory activity, patching and shielding of injured eye	NR	Bed rest with elevation of the head, bilateral patches and eye shield	NR	8/137

NR: not reported.